Leadership, Planning and Evaluation

项目摘要/摘要 马克·埃弗斯，医学博士，马基癌症中心(MCC)主任。埃弗斯博士的助手是 全国公认的癌症研究、临床护理、预防和教育领域的领导者，包括：Susanne M.Arnold医学博士(临床翻译副主任)；凯瑟琳·奥康纳博士(临床翻译副主任) 癌症教育和辅导)；Daret St.Clair博士(基础研究副主任)；Thomas Tucker，博士，公共卫生硕士(癌症预防和控制副主任)；Heidi Weiss，博士(助理 和David M.Gosky，硕士，MBA(行政协理主任)。这 自2009年以来，经验丰富的高级领导团队通力合作，确保 管理协调委员会的共同愿景和目标；促进基础、 MCC的翻译和临床部分；有效地利用大学的所有可用资源 肯塔基州、州和国家各级；参与临床试验、社区推广、教育和指导； 并监督管理委员会的所有活动。持续的规划和评估是发展和 MCC的持续卓越，有助于确保其强大的科学轨迹。规划和评估 活动通过外部和内部咨询委员会、主任理事会和 为主任和高级领导提供持续指导和支持的委员会。MCC外部 咨询委员会是主要的外部机制，负责审查和咨询管理委员会在 基础、翻译和社区研究，以及对MCC的领导和战略方向的监督。 内部规划和评估机制包括：管理协调委员会高级领导人的建议和支持， 正式由主任理事会、MCC研究方案负责人和共享资源基金组成 (SRF)董事；教育和指导委员会；以及由院长组成的内部咨询委员会， 该大学的中心主任和系主任。埃弗斯博士和高级领导层建立了 2009年MCC的第一个战略计划，作为指导发展的初步路线图 科学研究方案，重组为促进和实现科学目标所需的战略成果框架 以及对基础和翻译科学家的战略招聘，他们协同并进一步加强了 正在进行的研究工作。2012年，为了反映自埃弗斯博士到来以来所取得的巨大进步， 更新的计划重新定义了未来5年的战略目标，这是基于 地点。2017年，通过广泛的审查和审查程序，高级领导层制定了新的战略 围绕基础研究、癌症预防和控制、临床翻译、 教育和指导以及社区参与和外展。雄厚的制度基础 支助、慈善、战略框架、战略关系、行政和规划以及评价支持2017-- 2022年战略规划。

PROJECT SUMMARY/ABSTRACT B. Mark Evers, MD, serves as Director for the Markey Cancer Center (MCC). Dr. Evers is assisted by nationally recognized leaders in cancer research, clinical care, prevention and education, including: Susanne M. Arnold, MD (Associate Director for Clinical Translation); Kathleen O’Connor, PhD (Associate Director for Cancer Education and Mentoring); Daret St. Clair, PhD (Associate Director for Basic Research); Thomas Tucker, PhD, MPH (Associate Director for Cancer Prevention and Control); Heidi Weiss, PhD (Associate Director for Shared Resources); and David M. Gosky, MA, MBA (Associate Director for Administration). This highly experienced Senior Leadership team has worked together since 2009 to ensure consistency in the shared vision and goals of the MCC; foster synergistic and highly collaborative interactions among the basic, translational and clinical components of the MCC; effectively leverage all available resources at the University of Kentucky, state and national levels; engage in clinical trials, community outreach, education and mentoring; and oversee all activities of the MCC. Continual planning and evaluation are key to the development and sustained excellence of the MCC and helps ensure its strong scientific trajectory. Planning and evaluation activities are accomplished through the External and Internal Advisory Boards, the Director’s Council and committees that provide the Director and Senior Leadership ongoing guidance and support. The MCC External Advisory Board is the primary external mechanism that provides review and advice on the MCC’s progress in basic, translational and community research as well as oversight on MCC’s leadership and strategic direction. Internal planning and evaluation mechanisms include: the advice and support of MCC’s Senior Leaders, who formally comprise the Director’s Council; MCC Research Program Leaders and Shared Resource Facility (SRF) Directors; an Education and Mentoring Committee; and an Internal Advisory Board comprised of deans, center directors and department chairs at the university. Dr. Evers and the Senior Leadership established the first strategic plan for the MCC in 2009, which served as an initial road map to guide the development of scientific research programs, the reorganization of SRFs required to facilitate and achieve the scientific goals and strategic recruitments of basic and translational scientists who synergized and further strengthened the ongoing research efforts. In 2012, to reflect the tremendous progress that occurred since Dr. Evers’s arrival, an updated plan redefined the strategic goals for the next 5 years based on the strong foundations that were in place. In 2017, through an extensive review and vetting process, Senior Leadership developed a new strategic plan around pillars of excellence in basic research, cancer prevention and control, clinical translation, education and mentoring and community engagement and outreach. Strong foundations of institutional support, philanthropy, SRFs, strategic relations, administration and planning and evaluation support the 2017- 2022 Strategic Plan.